HARMONY BIOSCIENCES HOLDINGS (HRMY) Stock News
NASDAQ:HRMY - Nasdaq - US4131971040 - Common Stock - Currency: USD
HRMY Latest News, Press Relases and Analysis
Harmony Biosciences Holdings (NASDAQ:HRMY) – A Potentially Undervalued Stock in the Pharmaceutical Sector
Harmony Biosciences (HRMY) presents a compelling value opportunity with strong profitability, financial health, and growth—all at an attractive valuation.
Harmony Biosciences Holdings (NASDAQ:HRMY) – A Strong Growth Stock at a Reasonable Valuation
Harmony Biosciences (HRMY) offers strong growth, solid profitability, and an attractive valuation, making it a standout in the pharmaceuticals sector.
Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025
Photronics, Inc. (PLAB): A Bull Case Theory
We came across a bullish thesis on Photronics, Inc. (PLAB) on Enterprising Investor’s Substack by Tyler Moody. In this article, we will summarize the bulls’ thesis on PLAB. Photronics, Inc. (PLAB)’s share was trading at $18.11 as of 6th June. PLAB’s trailing P/E was 9.38 according to Yahoo Finance. Photronics (PLAB) appears to be an overlooked semiconductor […]
XPEL, Inc. (XPEL): A Bull Case Theory
We came across a bullish thesis on XPEL, Inc. (XPEL) on Leeder Capital’s Substack. In this article, we will summarize the bulls’ thesis on XPEL. XPEL, Inc. (XPEL)’s share was trading at $36.95 as of 6th June. XPEL’s trailing P/E was 21.48 according to Yahoo Finance. Xpel has emerged as a dominant force in automotive protective films […]
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory
We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Capital Curiosity’s Substack by Taylor Nichols. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. (HRMY)’s share was trading at $35.03 as of 5th June. HRMY’s trailing and forward P/E were 13.37 and 9.45 respectively according to Yahoo […]
Should Bitcoin Investors Be Concerned About the Recent Pullback?
After hitting a new all-time high above $111,000, Bitcoin has since pulled back to $105,000. Historically, market pullbacks have provided a good opportunity to "buy the dip" on Bitcoin. Bitcoin is actually becoming less volatile over time as it goes mainstream.
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
Harmony Biosciences Holdings ([NASDAQ:HRMY](https://www.chartmill.com/stock/quote/HRMY/profile)) – A Strong Growth Stock with Technical Breakout Potential
Harmony Biosciences (HRMY) shows strong growth, profitability, and a bullish technical pattern, making it a stock worth watching in the pharmaceuticals sector.
Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (13 Ratings)
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates
Harmony Biosciences (HRMY) delivered earnings and revenue surprises of 32.20% and 0.66%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: SWTX
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance
Why Harmony Biosciences (HRMY) Could Beat Earnings Estimates Again
Harmony Biosciences (HRMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know
Cue Biopharma (CUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CUE
Jim Cramer on Micron (MU): “No Catalyst, But You’re Buying Near the Low End”
We recently published a list of Jim Cramer Recently Discussed These 9 Stocks. In this article, we are going to take a look at where Micron Technology, Inc. (NASDAQ:MU) stands against other stocks that Jim Cramer discussed recently. Jim Cramer, the host of Mad Money, discussed the current economic outlook on Monday as he outlined […]
Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025
Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome
Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors
Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference
Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands
